TITLE

ACE Inhibitors/ARBs for Aortic Stenosis?

AUTHOR(S)
Boyle, Andrew J.
PUB. DATE
October 2011
SOURCE
Internal Medicine Alert;10/29/2011, Vol. 33 Issue 20, p156
SOURCE TYPE
Periodical
DOC. TYPE
Abstract
ABSTRACT
An abstract related to a research conducted on examining whether the use of angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is beneficial in patients with aortic stenosis (AS), is presented.
ACCESSION #
69591491

 

Related Articles

  • Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis? Shavelle, D. M. // Heart;Oct2005, Vol. 91 Issue 10, p1257 

    Questions as to whether angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis. Information on the initial studies of angiotensin converting enzyme inhibitors and aortic stenosis; Similarities between aortic stenosis and atherosclerosis; Limitations to the study of...

  • Use of ACE inhibitors in aortic stenosis. Lip, Gregory // Pulse;1/26/2004, Vol. 64 Issue 4, p66 

    Presents a question and answer advisory regarding the use of angiotensin converting enzyme (ACE) inhibitors in aortic stenosis. Effect of the decrease in systemic vascular resistance in patients without the obstruction to left ventricular outflow that occurs in aortic stenosis; Exacerbation by...

  • Taking precautions with ACE inhibitors. Kumar, A.; Asim, M.; Davison, A.M. // BMJ: British Medical Journal (International Edition);06/27/98, Vol. 316 Issue 7149, p1921 

    Editorial. Focuses on angiotensin converting enzyme inhibitors, which poses a danger for patients with unsuspected atherosclerotic renovascular disease. Effects of the drugs in unilateral diseases; Increase of renovascular diseases; What is the major cause of end stage renal failure; Details...

  • Images In Cardiology: Unicuspid aortic valve Krishnamoorthy, K M // Heart;Feb2001, Vol. 85 Issue 2, p217 

    The article offers information on a unicuspid unicommissural valve revealed through transoesophageal echocardiography in a 16-year-old boy with aortic stenosis.

  • 421 Prevalence and determinants of aortic sclerosis in patients with atherosclerosis Losi, M.A.; Brevetti, G.; Barbati, G.; D'Alessandro, G.; Schiano, V.; Cacace, A.; Betocchi, S.; Chiariello, M. // European Journal of Echocardiography;Dec2006 Supplement 1, Vol. 7, pS58 

    An abstract of the article "Prevalence and determinants of aortic sclerosis in patients with atherosclerosis," by M. A. Losi and colleagues is presented.

  • Medical Therapy for Calcific Aortic Stenosis. Salas, Maria J.; Santana, Orlando; Escolar, Esteban; Lamas, Gervasio A. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2012, Vol. 17 Issue 2, p133 

    Severe aortic stenosis due to calcification of the aortic valve is the most common indication for aortic valve replacement in the United States and Europe. The standard therapy for symptomatic patients with severe aortic stenosis is replacement of the valve. Some of the risk factors and...

  • MEDIKAMENTOZNI TRETMAN AORTNE STENOZE - ULOGA STATINA I INHIBITORA ANGIOTENZIN-KONVERUJUĆEG ENZIMA. DAVIČEVIĆ, Žaklina; TAVČIOVSKI, Dragan; MATUNOVIĆ, Radomir // Medicinski Pregled / Medical Review;2010, Vol. 63 Issue 1/2, p82 

    No abstract available.

  • Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study. Jiménez-Condil, J.; Bermejo, J.; Yotti, R.; Cortina, C.; Moreno, M.; Cantalapiedra, J. L.; García-Fernández, M. A. // Heart;Oct2005, Vol. 91 Issue 10, p1311 

    Objective: To determine the effects of angiotensin converting enzyme (ACE) inhibitors in hypertensive patients with aortic valve stenosis (AS). Design: Observational, drug withdrawal, single blinded study, with randomisation of the order of tests. Selling: Hypertension and asymptomatic AS....

  • THE LEFT VENTRICLE IN AORTIC STENOSIS: EVIDENCE FOR THE USE OF ACE INHIBITORS. Chambers, John // Heart;Mar2006, Vol. 92 Issue 3, p420 

    The article investigates the potential therapeutic benefits of ACE inhibitors in treating aortic stenosis. When aortic stenosis occurs, a combination of wall thickening and a change in cavity size in the left ventricle (LV) occurs. This carries the implication that the LV should be given greater...

  • TAVI in 2015: who, where and how? Pellikka, Patricia A. // Heart;Sep2015, Vol. 101 Issue 17, p1422 

    The article discusses a study on optimal management of patients at risks of aortic stenosis (AS). Topics discussed include progression of symptoms at a high rate, better survival of patients with aortic valve replacement (AVR), need to determine and diagnose if the patient is symptomatic to AS,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics